GHRL and Alzheimer disease: Several in vivo studies have identified ghrelin as a potential therapeutic agent in various neurological disorders, including AD, Parkinson’s disease, stroke, epilepsy, multiple sclerosis, and spinal cord injuries (Jeong et al. 2018; Miao et al. 2007; Moon et al. 2011).